These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27071967)

  • 21. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
    Peck KY; Lim YZ; Hopper I; Krum H
    Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Not Available].
    Muggli B; Gruner C
    Ther Umsch; 2016; 73(12):759-765. PubMed ID: 28462616
    [No Abstract]   [Full Text] [Related]  

  • 23. Diabetes mellitus and the risk of sudden cardiac death: A systematic review and meta-analysis of prospective studies.
    Aune D; Schlesinger S; Norat T; Riboli E
    Nutr Metab Cardiovasc Dis; 2018 Jun; 28(6):543-556. PubMed ID: 29730085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter Automatic Defibrillator Implantation Trial-Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocol.
    Kutyifa V; Beck C; Brown MW; Cannom D; Daubert J; Estes M; Greenberg H; Goldenberg I; Hammes S; Huang D; Klein H; Knops R; Kosiborod M; Poole J; Schuger C; Singh JP; Solomon S; Wilber D; Zareba W; Moss AJ;
    Am Heart J; 2017 Jul; 189():158-166. PubMed ID: 28625372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk assessment for sudden cardiac death in dialysis patients: how relevant are conventional cardiac risk factors?
    Saravanan P; Freeman G; Davidson NC
    Int J Cardiol; 2010 Oct; 144(3):431-2. PubMed ID: 19344968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.
    Choy B; Hansen E; Moss AJ; McNitt S; Zareba W; Goldenberg I;
    Am J Cardiol; 2010 Mar; 105(5):581-6. PubMed ID: 20185000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of sudden cardiac death.
    Cannom DS
    J Cardiovasc Electrophysiol; 2005 Sep; 16 Suppl 1():S21-4. PubMed ID: 16138880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
    Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
    Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventive effectiveness of implantable cardioverter defibrillator in reducing sudden cardiac death in the Chinese population: a multicenter trial of ICD therapy versus non-ICD therapy.
    Hua W; Niu H; Fan X; Ding L; Xu YZ; Wang J; Chen K; Wang F; Zhang S;
    J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S5-9. PubMed ID: 23140347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes and the Risk of Sudden Cardiac Death.
    Svane J; Pedersen-Bjergaard U; Tfelt-Hansen J
    Curr Cardiol Rep; 2020 Aug; 22(10):112. PubMed ID: 32770374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.
    Tanawuttiwat T; Garisto JD; Salow A; Glad JM; Szymkiewicz S; Saltzman HE; Kutalek SP; Carrillo RG
    Pacing Clin Electrophysiol; 2014 May; 37(5):562-8. PubMed ID: 24762055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction.
    Goldenberg I; Moss AJ; McNitt S; Zareba W; Andrews ML; Hall WJ; Greenberg H; Case RB;
    Am J Cardiol; 2006 Aug; 98(4):485-90. PubMed ID: 16893702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Non-pharmacologic prevention of sudden cardiac death].
    Jurkovicová O; Cagán S
    Bratisl Lek Listy; 1997; 98(7-8):423-39. PubMed ID: 9471337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetes, heart rate, and mortality.
    Singh N
    J Cardiovasc Pharmacol Ther; 2002 Apr; 7(2):117-29. PubMed ID: 12075400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survivors of ventricular fibrillation have persistent cardiovascular risk factors late in follow-up.
    Smith T; Theuns DA; Muskens-Heemskerk A; Deckers JW; Jordaens L
    Eur J Prev Cardiol; 2013 Feb; 20(1):161-7. PubMed ID: 22157513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sudden cardiac death in neuromuscular disorders.
    Finsterer J; Stöllberger C; Maeztu C
    Int J Cardiol; 2016 Jan; 203():508-15. PubMed ID: 26551884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implantable cardioverter defibrillator and survival after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark in the years 2001-2012, a nationwide study.
    Winther-Jensen M; Kjaergaard J; Lassen JF; Køber L; Torp-Pedersen C; Hansen SM; Lippert F; Kragholm K; Christensen EF; Hassager C
    Eur Heart J Acute Cardiovasc Care; 2017 Mar; 6(2):144-154. PubMed ID: 28058848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction.
    Ersbøll M; Valeur N; Andersen MJ; Mogensen UM; Vinther M; Svendsen JH; Møller JE; Kisslo J; Velazquez EJ; Hassager C; Søgaard P; Køber L
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):851-60. PubMed ID: 23850252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implantable cardioverter defibrillators: risks accompany the life-saving benefits.
    Atwater BD; Daubert JP
    Heart; 2012 May; 98(10):764-72. PubMed ID: 22422588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ambulatory ECG-based T-wave alternans predicts sudden cardiac death in high-risk post-MI patients with left ventricular dysfunction in the EPHESUS study.
    Stein PK; Sanghavi D; Domitrovich PP; Mackey RA; Deedwania P
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1037-42. PubMed ID: 18554193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.